ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.
about
H5N1 viruses and vaccinesAlphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaquesImmunity to influenza A H9N2 viruses induced by infection and vaccination.Developing vaccines against pandemic influenzaProtection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strainImmunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.Pathogenesis of influenza A (H5N1) virus infection in a primate model.Emerging respiratory viruses: challenges and vaccine strategiesISCOM-based vaccines: the second decade.Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine.Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination.Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protectionBaculovirus vector as a delivery vehicle for influenza vaccines.Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice.
P2860
Q21131612-68249D50-5A8E-4C8E-9BCA-84945AB15340Q24633851-B382FA90-1645-4696-8067-30DE20D48175Q30233611-3D0799BA-3058-4936-AE0F-8D12933C0534Q30329367-724C6076-1599-4D2D-BB6E-127FBB56ED10Q30351385-C56E7DA2-3B82-4ED4-863D-66EE2D456D91Q30363581-DE8E396E-C2CC-40D5-BF76-C623632736DBQ30373784-798FB9F8-8A74-4E0F-9BE2-ED6B36D0EA0DQ30389274-D7C6CE5E-AE05-4568-89F6-D0E4766921D1Q30399477-796D0786-6527-48FD-8F91-0B06A6BDF729Q33843811-0E2749BD-3C97-4F8F-B8E3-347C3A99BFCAQ35070868-9E24FD8C-83CA-4843-A7B6-2B993150A1C0Q36062124-77DF2104-64EF-4963-99EC-C15AC71CE2FCQ36316087-8DE4F9B9-7D12-4BC4-88D7-47D4ABEB675CQ36738797-6D019D2C-0954-406F-A8C9-74F8FCCACAEFQ37212827-A1BCBEB6-2C63-43E8-9368-D8C9BEDEA843Q37434539-2E9AC5DF-A127-4FD4-8F31-F6340C66CE91Q37812128-E956B26B-1ED7-450A-B14E-496B63D9C3A1Q40782869-CE104D0A-A892-4D3A-82F0-595CF3138B9B
P2860
ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@ast
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@en
type
label
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@ast
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@en
prefLabel
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@ast
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@en
P2093
P1433
P1476
ISCOM vaccine induced protecti ...... a human H5N1 influenza virus.
@en
P2093
Osterhaus AD
Rimmelzwaan GF
de Jong JC
van Amerongen G
P304
P356
10.1016/S0264-410X(98)00390-9
P407
P577
1999-03-01T00:00:00Z